What is Stoke Therapeutics, Inc.'s EV / EBITDA?

Stoke Therapeutics, Inc. (STOK) reported EV / EBITDA of 41.5× in Q3 2025.

What does EV / EBITDA mean?

Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.

Stoke Therapeutics, Inc. STOK EV / EBITDA

EV / EBITDA at other companies

Jazz PharmaceuticalsJAZZ

17.6×-4.0×

Harmony Biosciences Holdings, Inc.HRMY

5.6×-1.7×

Roivant SciencesROIV

1.8×—

Arrowhead ResearchARWR

27.4×—

ALN

Alnylam PharmaceuticalsALNY

52.6×—

Royalty PharmaRPRX

13.9×+1.7×

Other financials

Income statement

See full

Revenue$6.2M-96.1%

Operating income-$53.4M-148%

Net income-$50.0M-144%

EPS (diluted)-$0.79-142%

Balance sheet

See full

Cash & equivalents$155.7M-43.4%

Total debt$3.4M-42.5%

Total equity$394.9M+12.8%

Total assets$443.3M+8.9%

Cash flow

See full

Operating cash flow-$60.6M-146%

CapEx$353.0K+132%

Free cash flow-$60.9M-146%

Valuation

See full

Market cap$1.94B+436%

Enterprise value$1.79B+1,855%

P/S60.4×+58.5×

Profitability

See full

Operating margin-577.5%-597pp

Net margin-529.2%-556pp

FCF margin36.2%+18.4pp

Returns & leverage

See full

Return on equity-45.6%-66.1pp

Debt / equity0×0.0×

Current ratio9×+0.6×

Where this comes from

Calculated from Stoke Therapeutics, Inc.’s reported figures.

enterprise value/ebitda=41.5×

Based on the most recent quarter.

The official record: Stoke Therapeutics, Inc.’s 10-Q, filed November 4, 2025, on SEC EDGAR. View the filing →

Ask your AI about Stoke Therapeutics, Inc.'s ev / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Stoke Therapeutics, Inc.'s EV / EBITDA?: Stoke Therapeutics, Inc. (STOK) reported EV / EBITDA of 41.5× in Q3 2025.
What does EV / EBITDA mean?: Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.